Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
43.2M
-
Shares change
-
-24.2K
-
Total reported value, excl. options
-
$1.1B
-
Value change
-
-$196K
-
Number of buys
-
36
-
Number of sells
-
-29
-
Price
-
$25.37
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q3 2021
83 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q3 2021.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.2M shares
of 130M outstanding shares and own 33.25% of the company stock.
Largest 10 shareholders include FMR LLC (7.83M shares), TPG Group Holdings (SBS) Advisors, Inc. (4.25M shares), Abingworth LLP (4.17M shares), JANUS HENDERSON GROUP PLC (4.09M shares), RA CAPITAL MANAGEMENT, L.P. (3.9M shares), VANGUARD GROUP INC (3.04M shares), BlackRock Inc. (2.52M shares), FRAZIER MANAGEMENT LLC (2.31M shares), Medicxi Ventures Management (Jersey) Ltd (1.89M shares), and Pivotal bioVenture Partners Investment Advisor LLC (1.41M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.